Florian Bassermann

Summary

Affiliation: New York University
Country: USA

Publications

  1. ncbi Multisite phosphorylation of nuclear interaction partner of ALK (NIPA) at G2/M involves cyclin B1/Cdk1
    Florian Bassermann
    Department of Internal Medicine III, Technical University of Munich, 81675 Munich, Germany, and Department of Pathology, St Jude Chidren s Research Hospital, Memphis, TN 38105, USA
    J Biol Chem 282:15965-72. 2007
  2. ncbi Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA)
    Tao Ouyang
    Department of Internal Medicine III, Laboratory of Leukemogenesis, Technical University of Munich, 81675 Munich, Germany
    J Biol Chem 278:30028-36. 2003
  3. ncbi NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry
    Florian Bassermann
    Department of Internal Medicine III, Technical University of Munich, 81675 Munich, Germany
    Cell 122:45-57. 2005
  4. ncbi Phosphorylation of grb10 regulates its interaction with 14-3-3
    Susanne Urschel
    Department of Internal Medicine III, Laboratory of Leukemogenesis, Technical University of Munich, 81675 Munich, Germany
    J Biol Chem 280:16987-93. 2005
  5. ncbi APC/C(Cdh1)-mediated degradation of the F-box protein NIPA is regulated by its association with Skp1
    Christine von Klitzing
    Department of Internal Medicine ΙΙΙ, Technical University of Munich, Munich, Germany
    PLoS ONE 6:e28998. 2011
  6. ncbi Targeted inactivation of nuclear interaction partner of ALK disrupts meiotic prophase
    Anna Lena Illert
    Department of Internal Medicine III, Technical University of Munich, Munich 81675, Germany
    Development 139:2523-34. 2012
  7. ncbi Mitotic entry: a matter of oscillating destruction
    Florian Bassermann
    Department of Internal Medicine III, Technical University of Munich, Munich, Germany
    Cell Cycle 4:1515-7. 2005
  8. ncbi Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway
    Florian Bassermann
    Department of Internal Medicine III, Laboratory of Leukemogenesis, Technical University of Munich, 81675, Germany
    J Biol Chem 277:12437-45. 2002
  9. ncbi Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma
    Kathrin Abbrederis
    Third Department of Medicine (Hematology/Oncology, Institute for Medical Statistics and Epidemiology, and Munich Center for Clinical Studies, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    Ann Thorac Surg 82:293-7. 2006
  10. ncbi SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins
    Luca Busino
    Department of Pathology, NYU Cancer Institute, New York University School of Medicine, 550 First Avenue, MSB 599, New York, NY 10016, USA
    Science 316:900-4. 2007

Collaborators

  • Michele Pagano
  • Christian Peschel
  • Verena Voelter
  • Andreas Sendler
  • Thomas Jahn
  • Christine von Klitzing
  • Justus Duyster
  • Anna Lena Illert
  • Stephan W Morris
  • David Frescas
  • Luca Busino
  • Kathrin Abbrederis
  • Susanne Urschel
  • Ren Yuan Bai
  • Ren-Yuan Bai
  • Tao Ouyang
  • Cristina Antinozzi
  • Mitsuteru Hiwatari
  • Dirk G de Rooij
  • Marco Barchi
  • Hiroyuki Kawaguchi
  • Letitia Quintanilla-Martinez
  • Richard Huss
  • Astrid Fröschl
  • Sabine Wötzel
  • Daniele Guardavaccaro
  • Sofia I H Godinho
  • Ryo Koyama-Nasu
  • Giulio F Draetta
  • Choogon Lee
  • Patrick M Nolan
  • Alessio Maiolica
  • Joerg R Siewert
  • Raymonde Busch
  • Christoph Schuhmacher
  • Florian Lordick
  • Nadine Roethling
  • Silvia Münch
  • Cornelius Miething
  • Silvia Klumpen

Detail Information

Publications12

  1. ncbi Multisite phosphorylation of nuclear interaction partner of ALK (NIPA) at G2/M involves cyclin B1/Cdk1
    Florian Bassermann
    Department of Internal Medicine III, Technical University of Munich, 81675 Munich, Germany, and Department of Pathology, St Jude Chidren s Research Hospital, Memphis, TN 38105, USA
    J Biol Chem 282:15965-72. 2007
    ..Thus, cyclin B1/Cdk1 may contribute to the regulation of its own abundance in early mitosis...
  2. ncbi Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA)
    Tao Ouyang
    Department of Internal Medicine III, Laboratory of Leukemogenesis, Technical University of Munich, 81675 Munich, Germany
    J Biol Chem 278:30028-36. 2003
    ..These results implicate an antiapoptotic role for NIPA in NPM-ALK-mediated signaling events...
  3. ncbi NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry
    Florian Bassermann
    Department of Internal Medicine III, Technical University of Munich, 81675 Munich, Germany
    Cell 122:45-57. 2005
    ..Thus, SCF(NIPA)-based ubiquitination may regulate S-phase completion and mitotic entry in the mammalian cell cycle...
  4. ncbi Phosphorylation of grb10 regulates its interaction with 14-3-3
    Susanne Urschel
    Department of Internal Medicine III, Laboratory of Leukemogenesis, Technical University of Munich, 81675 Munich, Germany
    J Biol Chem 280:16987-93. 2005
    ..Based on these findings, we propose a regulatory circuitry involving a phosphorylation-regulated complex formation of Grb10 with 14-3-3 and Akt...
  5. ncbi APC/C(Cdh1)-mediated degradation of the F-box protein NIPA is regulated by its association with Skp1
    Christine von Klitzing
    Department of Internal Medicine ΙΙΙ, Technical University of Munich, Munich, Germany
    PLoS ONE 6:e28998. 2011
    ..Our data thus define a novel mode of regulating APC/C-mediated ubiquitination...
  6. ncbi Targeted inactivation of nuclear interaction partner of ALK disrupts meiotic prophase
    Anna Lena Illert
    Department of Internal Medicine III, Technical University of Munich, Munich 81675, Germany
    Development 139:2523-34. 2012
    ..Moreover, we show nuclear accumulation of cyclin B1 with a subsequent premature increase in G2/M kinase activity in Nipa-/- spermatocytes. Together, these results reveal a novel role for NIPA in meiosis...
  7. ncbi Mitotic entry: a matter of oscillating destruction
    Florian Bassermann
    Department of Internal Medicine III, Technical University of Munich, Munich, Germany
    Cell Cycle 4:1515-7. 2005
    ..Thus, oscillating ubiquitination of nuclear cyclin B1 driven by the SCFNIPA complex contributes to the timing of mitotic entry in the mammalian cell cycle...
  8. ncbi Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway
    Florian Bassermann
    Department of Internal Medicine III, Laboratory of Leukemogenesis, Technical University of Munich, 81675, Germany
    J Biol Chem 277:12437-45. 2002
    ....
  9. ncbi Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma
    Kathrin Abbrederis
    Third Department of Medicine (Hematology/Oncology, Institute for Medical Statistics and Epidemiology, and Munich Center for Clinical Studies, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    Ann Thorac Surg 82:293-7. 2006
    ..There were no erythropoietin-related adverse events. CONCLUSIONS: Treatment with erythropoietin is effective and well tolerated in patients with esophagogastric adenocarcinoma who experience anemia during neoadjuvant chemotherapy...
  10. ncbi SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins
    Luca Busino
    Department of Pathology, NYU Cancer Institute, New York University School of Medicine, 550 First Avenue, MSB 599, New York, NY 10016, USA
    Science 316:900-4. 2007
    ..Silencing of Fbxl3 produced no effect in Cry1-/-;Cry2-/- cells, which shows that Fbxl3 controls clock oscillations by mediating the degradation of CRY proteins...
  11. ncbi JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes
    David Frescas
    Department of Pathology, NYU Cancer Institute, New York University School of Medicine, 550 First Avenue, New York, New York 10016, USA
    Nature 450:309-13. 2007
    ....
  12. ncbi The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint
    Florian Bassermann
    Department of Pathology, NYU Cancer Institute, New York University School of Medicine, 550 First Avenue, MSB 599, New York, NY 10016, USA
    Cell 134:256-67. 2008
    ..These findings define a novel pathway that is crucial for the G2 DNA-damage-response checkpoint...